These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1336341)

  • 1. The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.
    Furman PA; Davis M; Liotta DC; Paff M; Frick LW; Nelson DJ; Dornsife RE; Wurster JA; Wilson LJ; Fyfe JA
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2686-92. PubMed ID: 1336341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular metabolism of (-)- and (+)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in HepG2 derivative 2.2.15 (subclone P5A) cells.
    Paff MT; Averett DR; Prus KL; Miller WH; Nelson DJ
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1230-8. PubMed ID: 8092819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model.
    Condreay LD; Jansen RW; Powdrill TF; Johnson LC; Selleseth DW; Paff MT; Daluge SM; Painter GR; Furman PA; Ellis MN
    Antimicrob Agents Chemother; 1994 Mar; 38(3):616-9. PubMed ID: 7515609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, oral bioavailability, and metabolic disposition in rats of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, a nucleoside analog active against human immunodeficiency virus and hepatitis B virus.
    Frick LW; St John L; Taylor LC; Painter GR; Furman PA; Liotta DC; Furfine ES; Nelson DJ
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2285-92. PubMed ID: 8285607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.
    Schinazi RF; McMillan A; Cannon D; Mathis R; Lloyd RM; Peck A; Sommadossi JP; St Clair M; Wilson J; Furman PA
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2423-31. PubMed ID: 1283296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (524W91) inhibits hepatitis B virus replication in primary human hepatocytes.
    Condreay LD; Condreay JP; Jansen RW; Paff MT; Averett DR
    Antimicrob Agents Chemother; 1996 Feb; 40(2):520-3. PubMed ID: 8834915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay.
    Jansen RW; Johnson LC; Averett DR
    Antimicrob Agents Chemother; 1993 Mar; 37(3):441-7. PubMed ID: 8384813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5'-triphosphates of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolane-5-yl]cytosine equally inhibit human immunodeficiency virus type 1 reverse transcriptase.
    Wilson JE; Martin JL; Borroto-Esoda K; Hopkins S; Painter G; Liotta DC; Furman PA
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1720-2. PubMed ID: 7692813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.
    Cullen JM; Smith SL; Davis MG; Dunn SE; Botteron C; Cecchi A; Linsey D; Linzey D; Frick L; Paff MT; Goulding A; Biron K
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2076-82. PubMed ID: 9333028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity of the antiviral enantiomers of oxathiolane cytosine nucleosides for human 2'-deoxycytidine kinase.
    Shewach DS; Liotta DC; Schinazi RF
    Biochem Pharmacol; 1993 Apr; 45(7):1540-3. PubMed ID: 8385948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virus.
    Frick LW; Lambe CU; St John L; Taylor LC; Nelson DJ
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2722-9. PubMed ID: 7695253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure nucleoside enantiomers of beta-2',3'-dideoxycytidine analogs are selective inhibitors of hepatitis B virus in vitro.
    Schinazi RF; Gosselin G; Faraj A; Korba BE; Liotta DC; Chu CK; Mathé C; Imbach JL; Sommadossi JP
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2172-4. PubMed ID: 7811039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-human immunodeficiency virus and anti-hepatitis-B virus activities and toxicities of the enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine and their 5-fluoro analogues in vitro.
    Mansour TS; Jin H; Wang W; Hooker EU; Ashman C; Cammack N; Salomon H; Belmonte AR; Wainberg MA
    J Med Chem; 1995 Jan; 38(1):1-4. PubMed ID: 7837220
    [No Abstract]   [Full Text] [Related]  

  • 15. Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication.
    Chang CN; Doong SL; Zhou JH; Beach JW; Jeong LS; Chu CK; Tsai CH; Cheng YC; Liotta D; Schinazi R
    J Biol Chem; 1992 Jul; 267(20):13938-42. PubMed ID: 1321132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir.
    Shaw T; Mok SS; Locarnini SA
    Hepatology; 1996 Nov; 24(5):996-1002. PubMed ID: 8903366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activities and cellular toxicities of modified 2',3'-dideoxy-2',3'-didehydrocytidine analogues.
    Stuyver LJ; Lostia S; Adams M; Mathew JS; Pai BS; Grier J; Tharnish PM; Choi Y; Chong Y; Choo H; Chu CK; Otto MJ; Schinazi RF
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3854-60. PubMed ID: 12435688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
    Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
    World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of replication of hepatitis B virus by cytallene in vitro.
    Zhu YL; Pai SB; Liu SH; Grove KL; Jones BC; Simons C; Zemlicka J; Cheng YC
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1755-60. PubMed ID: 9257755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracil.
    Balakrishna Pai S; Liu SH; Zhu YL; Chu CK; Cheng YC
    Antimicrob Agents Chemother; 1996 Feb; 40(2):380-6. PubMed ID: 8834884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.